Enteropathic arthropathy explained

Enteropathic arthropathy
Synonyms:Enteropathic Arthritis
Pronounce:/ɛntɹəpæθɪk/[1] är-ˈthrä-pə-thē[2]
Complications:Chronic arthritis, and toxicity of therapy.[3]
Cause:-->
Risks:Crohn's disease, ulcerative colitis, inflammatory bowel diseases, Whipple's disease, celiac disease, and intestinal bypass surgery.
Differential:Fibromyalgia, Poncet disease, Reactive arthritis, Bowel–associated dermatosis-arthritis syndrome, Bechet disease, Hypertrophic osteoarthropathy, and SAPHO syndrome.[4]
Management:-->
Incidence:or
Prevalence:-->
Eponym:-->

Enteropathic arthropathy commonly referred to as enteropathic arthritis, is a type of arthritis linked to Crohn's disease, ulcerative colitis, and chronic inflammatory bowel diseases.[5]

Along with reactive arthritis, psoriatic arthritis, and idiopathic ankylosing spondylitis, this type of arthritis is categorized as a seronegative spondyloarthropathy.[5]

Other gastrointestinal disorders like Whipple's disease, celiac disease, and intestinal bypass surgery for severe obesity can also cause joint involvement. The pathogenesis of arthritis in these conditions is likely influenced by immunologic, genetic, and abnormal bowel permeability factors, though the precise mechanisms are still unknown.[5]

Signs and symptoms

Historically, there have been two main patterns of joint involvement with enteropathic arthritis: axial involvement, which includes sacroiliitis with or without spondylitis resembling idiopathic ankylosing spondylitis, and peripheral arthritis. Additional conditions that may manifest are enthesopathy, tendinitis, and a variety of other conditions such as periostitis, clubbing, and granulomatous lesions of the bone and joint.[6]

Two types of peripheral arthritis have been identified. Pauciarticular arthritis, or type I, usually affects fewer than five major weight-bearing joints. It usually has an asymmetrical pattern and is linked to active bowel disease; monoarthritis isn't uncommon. Both big and small joints are affected, mainly lower limb joints like the metatarsophalangeal joints, ankles, and knees. Shoulder and hip arthritis is less common and is typically linked to spondylitis and sacroiliitis.[7] It does not cause joint deformities, but it is typically migratory, transitory, and recurrent.[8] Joint symptoms, particularly in Crohn's disease, can manifest before bowel symptoms do. In ulcerative colitis, the time of the initial arthritis attack appears to be unrelated to the length of the colitis. Furthermore, a relapse of peripheral arthritis is often associated with a flare-up of the gut symptoms, primarily in ulcerative colitis.[7]

Polyarthritis type II primarily affects the small joints. Rarely does it come before an IBD diagnosis. It usually progresses on its own schedule apart from the bowel illness. Months may pass during an active synovitis episode, and it may recur frequently. Years may pass between periods of exacerbations and remissions.[7]

The spectrum of axial involvement includes true ankylosing spondylitis, which is characterized by classic clinical and radiologic features, as well as asymptomatic sacroiliitis and inflammatory pain in the lower back regardless of the radiological evidence of the condition. Axial involvement may occur years before bowel disease. Inflammatory low back pain, buttocks pain, and chest pain are the main complaints. Typically occurring before the age of 45, inflammatory back pain often begins slowly, is often unilateral, sporadic, and worsens while at rest. It can also be aggravated by coughing or sneezing, worsen in the morning, and cause fatigue. The pain persists for at least three months. Enthesitis of the manubriocostal, costosternal, and costovertebral articulations causes thoracic pain. It worsens with coughing and deep inspirations, and it restricts the expansion of the respiratory system with varying-length episodes. Ankylosing spondylitis has been linked with dactylitis. It is distinguished by tenosynovitis that affects the flexor tendons resulting in inflammatory swelling in one or more fingers or toes. One of the main indicators that the disease is progressing toward generalized ankylosis is the restriction of cervical spine mobility.[7]

Causes

It is unknown what exactly causes the enteropathic arthropathies. Increased permeability from GI tract inflammation can lead to the absorption of antigenic substances, such as bacterial antigens. The musculoskeletal tissues, such as entheses and the synovial membrane, may then localize these arthrogenic antigens, triggering an inflammatory response. Alternatively, by means of molecular mimicry, which involves the host's immune system reacting to these antigens in a cross-reaction with self-antigens present in the synovial membrane and other target organs, an autoimmune response may be triggered.[9]

Risk factors

Depending on the study population as well as the definitions used, systemic disorders such as inflammatory bowel disease (IBD), Crohn's disease (CD), and ulcerative colitis (UC) may be made worse by external manifestations in up to 40% of patients. In IBD, rheumatological manifestations are common and include secondary osteoporosis, secondary hypertrophic osteoarthropathy, axial involvement, peripheral enthesitis, and peripheral arthritis.

Whipple's disease is an uncommon multisystem illness caused by a bacteria called Tropheryma whippelii. Clinical manifestations include dementia, polyarthralgia, low-grade fever, diarrhea, weight loss, lymphadenopathy, and neuropsychiatric symptoms.[10] Arthralgia, as well as arthritis, are the sole signs in 67% of patients, and they may appear years before other symptoms.[11] A case series comprising twenty-five patients with Whipple's disease-related arthropathy revealed that symmetric migratory polyarthritis, primarily affecting the knees, ankles, and wrists, was the most prevalent pattern.[12] Up to 40% of patients have been reported to have axial involvement with lumbar and sacroiliac tenderness.[13] Radiologic signs resembling those of ankylosing spondylitis have also been observed.[14]

Celiac disease is a type of gluten-sensitive enteropathy marked by small intestinal mucosal abnormalities, particularly villous flattening, and atrophy, which leads to malabsorption. Among the numerous clinical signs and symptoms of malabsorption are dermatitis herpetiformis, weight loss, diarrhea, and anemia.[15] First documented in 1982, there is a specific link between celiac disease and inflammatory arthritis.[16] Large joints like the knees, hips, and shoulders are commonly affected by polyarticular symmetrical arthritis, which is the most frequently reported articular pattern.[17] There have also been reports of polyarticular small and large joint arthropathy,[18] oligoarthritis,[19] and monoarthritis.[20] Axial along with peripheral arthritis is linked to celiac disease and can sometimes occur in adults and children[21] before or without bowel symptoms.[22]

In an effort to treat morbid obesity, small intestine bypass surgeries first emerged in the 1950s. The goal was to decrease the absorptive surface of the gut. In 20% to 80% of patients, postoperative arthritis-dermatitis syndrome and several metabolic side effects occur. When the jejunoileal bypass was used in place of the jejunocolonic bypass, similar problems still occurred.[23] Though mono- and oligoarthritis have also been reported, the typical clinical presentation is a migratory non-erosive seronegative polyarthritis affecting the ankles, wrists, shoulders, hands, and fingers.[24] Usually, the arthritis appears two to three years following the surgery.[25] Intestinal bypass arthritis has been linked to the overgrowth of bacteria in the blind loop segment of the bowel, and immunologic involvement appears likely due to the presence of immune complexes in the serum.[26] Reversing the bypass surgery is typically linked to a total and permanent remission of the arthritis, providing more proof of the connection between intestines and joint pathology.[24]

Diagnosis

No pathognomonic finding exists to support a diagnosis of IBD-related arthritis. In the appropriate clinical context, a suspicion of the diagnosis may arise. Radiographs of the pelvis and spine may reveal characteristic features of sacroiliitis and ankylosing spondylitis. The latter is usually bilateral, though reports have indicated a higher incidence of zygapophyseal joint ankylosis and asymmetric sacroiliitis. Although erosive lesions, primarily of the metatarsal joints, are reported, radiographic changes are typically not associated with peripheral joint involvement. Certain characteristics of these lesions differ from those of rheumatoid arthritis, such as the absence of osteoporosis as well as the presence of neighboring bone proliferation. Occasionally, a damaging granulomatous synovitis linked to Crohn's disease may be observed. Radiographically, enteropathies are similar to those observed in other spondyloarthritis.

Treatment

Establishing the efficacy of therapy can be challenging in certain patients due to the episodic nature of their arthropathy. Simple interventions like rest, splintsintra-articular steroid injections, and physical therapy are used to treat many patients.

NSAIDs are usually effective in treating spondyloarthropathy patients; however, they should be used cautiously as they may worsen IBD[27] and have been linked to ulcerations in both the large and small intestines.[28]

Controlling intestinal inflammation is the primary treatment objective for peripheral arthritis, as the disease's activity frequently resembles that of bowel disease. For ulcerative colitis, sulfasalazine has been demonstrated to be beneficial in treating flare-ups as well as the underlying condition;[29] however, the picture for Crohn's disease is less clear. Sulfasalazine has been demonstrated to be beneficial in certain trials for Crohn's disease,[30] but not in others.[31]

The development of targeted biological treatments has had an impact on enteropathic arthritis management. Psoriatic arthritis,[32] [33] enthesopathy linked to spondyloarthropathy,[34] and refractory ankylosing spondylitis[35] can all benefit from biological blockade using the TNFa antagonists etanercept and infliximab. Infliximab is also useful in reducing spondyloarthropathy and intestinal inflammation in Crohn's disease patients.[36] Etanercept did not affect bowel disease, but anecdotal evidence points to etanercept's potential benefit in treating spondyloarthritis linked to Crohn's disease, including MRI-demonstrated resolution of spondylitis.[37]

See also

Further reading

External links

Notes and References

  1. Web site: How do you pronounce... » Help You to Learn English with Youtube » YThi . YThi . November 6, 2019 . December 8, 2023.
  2. Web site: Definition of ARTHROPATHY . Merriam-Webster . December 7, 2023 . December 8, 2023.
  3. Minerva P . Enteropathic Arthropathies: Practice Essentials, Etiology, Epidemiology . Medscape Reference . November 15, 2021 . December 10, 2023.
  4. Book: Shahid Z, Lucke M . Enteropathic Arthritis . StatPearls . StatPearls Publishing . July 17, 2023 . 37603630 . https://www.ncbi.nlm.nih.gov/books/NBK594239/ . December 10, 2023.
  5. Holden W, Orchard T, Wordsworth P . Enteropathic arthritis . Rheumatic Disease Clinics of North America . 29 . 3 . 513–30, viii . August 2003 . 12951865 . 10.1016/s0889-857x(03)00043-7 . Elsevier BV .
  6. De Keyser F, Elewaut D, De Vos M, De Vlam K, Cuvelier C, Mielants H, Veys EM . Bowel inflammation and the spondyloarthropathies . Rheumatic Disease Clinics of North America . 24 . 4 . 785–813 . November 1998 . 9891711 . 10.1016/s0889-857x(05)70042-9 . Elsevier BV .
  7. Voulgari PV . Rheumatological manifestations in inflammatory bowel disease . Annals of Gastroenterology . 24 . 3 . 173–180 . 2011 . 24713717 . 3959315 . The Hellenic Society of Gastroenterology .
  8. Wordsworth P . Arthritis and inflammatory bowel disease . Current Rheumatology Reports . 2 . 2 . 87–88 . April 2000 . 11123044 . 10.1007/s11926-000-0045-3 . Springer Science and Business Media LLC . 35543053 .
  9. Minerva P . Enteropathic Arthropathies: Practice Essentials, Etiology, Epidemiology . Medscape Reference . November 15, 2021 . December 9, 2023.
  10. Kucharz EJ, Kramza J, Grosicka A, Pieczyrak R . Clinical manifestations of Whipple's disease mimicking rheumatic disorders . Reumatologia . 59 . 2 . 104–110 . April 27, 2021 . 33976464 . 8103404 . 10.5114/reum.2021.105418 . Termedia Sp. z.o.o. . free .
  11. Durand DV, Lecomte C, Cathébras P, Rousset H, Godeau P . Whipple disease. Clinical review of 52 cases. The SNFMI Research Group on Whipple Disease. Société Nationale Française de Médecine Interne . Medicine . 76 . 3 . 170–184 . May 1997 . 9193452 . 10.1097/00005792-199705000-00003 . Ovid Technologies (Wolters Kluwer Health) . free .
  12. Weiner SR, Utsinger P . Whipple disease . Seminars in Arthritis and Rheumatism . 15 . 3 . 157–167 . February 1986 . 2421412 . 10.1016/0049-0172(86)90013-2 . Elsevier BV .
  13. Khan MA . Axial arthropathy in Whipple's disease . The Journal of Rheumatology . 1982 . 9 . 6 . 928–929 . 6186807 . J Rheumatol .
  14. Ayoub WT, Davis DE, Torretti D, Viozzi FJ . Bone destruction and ankylosis in Whipple's disease . The Journal of Rheumatology . 9 . 6 . 930–931 . 1982 . 6186808 . 9 December 2023 .
  15. Mäki M, Collin P . Coeliac disease . Lancet . 349 . 9067 . 1755–1759 . June 1997 . 9193393 . 10.1016/s0140-6736(96)70237-4 . Elsevier BV . 40153030 .
  16. Adelizzi RA, Pecora AA, Chiesa JC . Celiac disease: case report with an associated arthropathy . The American Journal of Gastroenterology . 77 . 7 . 481–485 . July 1982 . 7091138 . Am J Gastroenterol .
  17. Bourne JT, Kumar P, Huskisson EC, Mageed R, Unsworth DJ, Wojtulewski JA . Arthritis and coeliac disease . Annals of the Rheumatic Diseases . 44 . 9 . 592–598 . September 1985 . 3876079 . 1001716 . 10.1136/ard.44.9.592 . BMJ . free .
  18. McDonagh JE, Griffiths ID . Arthritis--a presenting feature of occult coeliac disease . British Journal of Rheumatology . 31 . 12 . 857–858 . December 1992 . 1458297 . 10.1093/rheumatology/31.12.857-a .
  19. Collin P, Korpela M, Hällström O, Viander M, Keyriläinen O, Mäki M . Rheumatic complaints as a presenting symptom in patients with coeliac disease . Scandinavian Journal of Rheumatology . 21 . 1 . 20–23 . 1992 . 1570482 . 10.3109/03009749209095057 . Informa UK Limited .
  20. Borg AA, Dawes PT, Swan CH, Hothersall TE . Persistent monoarthritis and occult coeliac disease . Postgraduate Medical Journal . 70 . 819 . 51–53 . January 1994 . 8140024 . 2397588 . 10.1136/pgmj.70.819.51 . Oxford University Press (OUP) . free .
  21. Mäki M, Hallström O, Verronen P, Reunala T, Lähdeaho ML, Holm K, Visakorpi JK . Reticulin antibody, arthritis, and coeliac disease in children . Lancet . 1 . 8583 . 479–480 . February 1988 . 2893907 . 10.1016/s0140-6736(88)91280-9 . Elsevier BV . 41488212 .
  22. Chakravarty K, Scott DG . Oligoarthritis--a presenting feature of occult coeliac disease . British Journal of Rheumatology . 31 . 5 . 349–350 . May 1992 . 10.1093/rheumatology/31.5.349 . Oxford University Press (OUP) . 1581779 .
  23. Shagrin JW, Frame B, Duncan H . Polyarthritis in obese patients with intestinal bypass . Annals of Internal Medicine . 75 . 3 . 377–380 . September 1971 . 5568149 . 10.7326/0003-4819-75-3-377 . American College of Physicians .
  24. Delamere JP, Baddeley RM, Walton KW . Jejuno-ileal bypass arthropathy: its clinical features and associations . Annals of the Rheumatic Diseases . 42 . 5 . 553–557 . October 1983 . 6625703 . 10.1136/ard.42.5.553 . BMJ . 1001295 . free .
  25. Clegg DO, Zone JJ, Samuelson CO, Ward JR . Circulating immune complexes containing secretory IgA in jejunoileal bypass disease . Annals of the Rheumatic Diseases . 44 . 4 . 239–244 . April 1985 . 3985690 . 1001619 . 10.1136/ard.44.4.239 . BMJ . free .
  26. Utsinger PD . Systemic immune complex disease following intestinal bypass surgery: bypass disease . Journal of the American Academy of Dermatology . 2 . 6 . 488–495 . June 1980 . 6447168 . 10.1016/s0190-9622(80)80149-6 . Elsevier BV .
  27. Kaufmann HJ, Taubin HL . Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease . Annals of Internal Medicine . 107 . 4 . 513–516 . October 1987 . 3498419 . 10.7326/0003-4819-107-4-513 . American College of Physicians .
  28. Bjarnason I, Hayllar J, MacPherson AJ, Russell AS . Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans . Gastroenterology . 104 . 6 . 1832–1847 . June 1993 . 8500743 . 10.1016/0016-5085(93)90667-2 . Elsevier BV . free .
  29. Dissanayake AS, Truelove SC . A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin) . Gut . 14 . 12 . 923–926 . December 1973 . 4150435 . 1412871 . 10.1136/gut.14.12.923 . BMJ . free .
  30. Van Hees PA, Van Lier HJ, Van Elteren PH, Driessen M, Van Hogezand RA, Ten Velde GP, Bakker JH, Van Tongeren JH . 6 . Effect of sulphasalazine in patients with active Crohn's disease: a controlled double-blind study . Gut . 22 . 5 . 404–409 . May 1981 . 6114023 . 1419240 . 10.1136/gut.22.5.404 . BMJ . free .
  31. Wenckert A, Kristensen M, Eklund AE, Barany F, Jarnum S, Worning H, Folkenborg O, Holtz A, Bonnevie O, Riis P . 6 . The long-term prophylactic effect of salazosulphapyridine (Salazopyrin) in primarily resected patients with Crohn's disease. A controlled double-blind trial . Scandinavian Journal of Gastroenterology . 13 . 2 . 161–167 . 1978 . 24891 . 10.3109/00365527809181743 . Informa UK Limited .
  32. Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ . Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial . Lancet . 356 . 9227 . 385–390 . July 2000 . 10972371 . 10.1016/s0140-6736(00)02530-7 . Elsevier BV . 9392760 .
  33. Antoni C, Manger B . Infliximab for psoriasis and psoriatic arthritis . Clinical and Experimental Rheumatology . 20 . 6 Suppl 28 . S122–S125 . 2002 . 12463461 . 10 December 2023 .
  34. Marzo-Ortega H, McGonagle D, O'Connor P, Emery P . Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: a clinical and magnetic resonance imaging study . Arthritis and Rheumatism . 44 . 9 . 2112–2117 . September 2001 . 11592375 . 10.1002/1529-0131(200109)44:9<2112::AID-ART363>3.0.CO;2-H .
  35. Brandt J, Haibel H, Cornely D, Golder W, Gonzalez J, Reddig J, Thriene W, Sieper J, Braun J . 6 . Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab . Arthritis and Rheumatism . 43 . 6 . 1346–1352 . June 2000 . 10857793 . 10.1002/1529-0131(200006)43:6<1346::AID-ANR18>3.0.CO;2-E .
  36. Van den Bosch F, Kruithof E, De Vos M, De Keyser F, Mielants H . Crohn's disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms . Lancet . 356 . 9244 . 1821–1822 . November 2000 . 11117919 . 10.1016/s0140-6736(00)03239-6 . Elsevier BV . 1799909 .
  37. Marzo-Ortega H, McGonagle D, O'Connor P, Emery P . Efficacy of etanercept for treatment of Crohn's related spondyloarthritis but not colitis . Annals of the Rheumatic Diseases . 62 . 1 . 74–76 . January 2003 . 12480676 . 1754306 . 10.1136/ard.62.1.74 . BMJ . free .